Getagraph.com logo
S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(0.15%) $79.07
Gas
(-0.64%) $2.02
Gold
(-0.01%) $2 309.40
Silver
(0.10%) $26.86
Platinum
(0.38%) $966.30
USD/EUR
(-0.07%) $0.932
USD/NOK
(-0.10%) $10.98
USD/GBP
(-0.15%) $0.797
USD/RUB
(1.50%) $92.49

Realaus laiko atnaujinimai Teva Pharmaceutical [TEVJF]

Birža: OTC Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-08)

Expected move: +/- 0.00%

Atnaujinta19 bal. 2024 @ 17:08
25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 11.75

Live Chart Being Loaded With Signals

Commentary (19 bal. 2024 @ 17:08):

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally...

Stats
Šios dienos apimtis 12.00
Vidutinė apimtis 1 908.00
Rinkos kapitalizacija 13.17B
EPS $0.0705 ( 2023-09-29 )
Kita pelno data ( $0 ) 2024-05-08
Last Dividend $0.345 ( 2017-06-05 )
Next Dividend $0 ( N/A )
P/E -23.50
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-11-20 Fox Christine Buy 253 968 Restricted Share Units
2023-11-20 Fox Christine Buy 0
2023-11-15 Conway Vikki L Buy 33 482 Restricted Share Units
2023-11-15 Bergwerk Dov Buy 33 482 Restricted Share Units
2023-10-13 Bergwerk Dov Sell 0 Ordinary Shares
INSIDER POWER
23.25
Last 96 transactions
Buy: 1 572 847 | Sell: 982 807

Teva Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Teva Pharmaceutical Finansinės ataskaitos

Annual 2023
Pajamos: $15.85B
Bruto pelnas: $7.65B (48.25 %)
EPS: $-0.500
FY 2023
Pajamos: $15.85B
Bruto pelnas: $7.65B (48.25 %)
EPS: $-0.500
FY 2022
Pajamos: $14.93B
Bruto pelnas: $6.97B (46.72 %)
EPS: $-2.19
FY 2021
Pajamos: $15.88B
Bruto pelnas: $7.60B (47.83 %)
EPS: $0.380

Financial Reports:

No articles found.

Teva Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

Teva Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.52 - low (50.11%) | Divividend Growth Potential Score: 0.653 - No dividend growth expected in the near future
Information
First Dividend $0.346 2014-02-24
Last Dividend $0.345 2017-06-05
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 7 --
Total Paid Out $2.38 --
Avg. Dividend % Per Year 0.00% --
Score 1.85 --
Div. Sustainability Score 4.52
Div.Growth Potential Score 0.653
Div. Directional Score 2.59 --
Next Divdend (Est)
 (2024-07-05)
$0 Estimate 0.00 %
Dividend Stability
0.04 Very Bad
Dividend Score
1.85
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PEBC Ex Dividend Knight 2023-09-08 Semi-Annually 0 0.00%
DTRL Ex Dividend Knight 2023-07-07 Quarterly 0 0.00%
UEPCO Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
JRONY Ex Dividend Knight 2023-05-15 Annually 0 0.00%
BNPQY Ex Dividend Junior 2023-05-18 Annually 0 0.00%
RNMBY Ex Dividend Knight 2023-05-10 Annually 0 0.00%
FBTT Ex Dividend Junior 2023-09-21 Quarterly 0 0.00%
WFAFY Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
LRENY Ex Dividend Knight 2023-06-30 Quarterly 0 0.00%
CIHKY Ex Dividend Junior 2023-07-03 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.03741.500-0.748-1.123[0 - 0.5]
returnOnAssetsTTM-0.01361.200-0.455-0.546[0 - 0.3]
returnOnEquityTTM-0.08081.500-2.01-3.01[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.0190.8009.907.92[1 - 3]
quickRatioTTM0.5420.800-1.520-1.216[0.8 - 2.5]
cashRatioTTM0.2631.5009.6510.00[0.2 - 2]
debtRatioTTM0.464-1.5002.27-3.41[0 - 0.6]
interestCoverageTTM0.9141.000-0.773-0.773[3 - 30]
operatingCashFlowPerShareTTM1.2202.009.5910.00[0 - 30]
freeCashFlowPerShareTTM0.7512.009.6210.00[0 - 20]
debtEquityRatioTTM2.68-1.50010.00-10.00[0 - 2.5]
grossProfitMarginTTM0.4821.0005.295.29[0.2 - 0.8]
operatingProfitMarginTTM0.05931.000-0.814-0.814[0.1 - 0.6]
cashFlowToDebtRatioTTM0.06791.000-0.734-0.734[0.2 - 2]
assetTurnoverTTM0.3640.800-0.904-0.723[0.5 - 2]
Total Score4.52

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-22.211.000-2.340[1 - 100]
returnOnEquityTTM-0.08082.50-1.292-3.01[0.1 - 1.5]
freeCashFlowPerShareTTM0.7512.009.7510.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.2202.009.5910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.2561.500-5.040[0.5 - 2]
operatingCashFlowSalesRatioTTM0.08631.000-0.3420[0.1 - 0.5]
Total Score0.653

Teva Pharmaceutical

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.